136 Comprehensive analysis of tumor immune landscape by a 17-plex immunofluorescence assay on the Orion platform
Richard Van Krieken(Lineage Cell Therapeutics (United States)), Jennifer Bordeaux(Lineage Cell Therapeutics (United States)), Margaret McLaughlin(University of Southern California), Naveen Dakappagari(Navidea Biopharmaceuticals (United States)), Xun Li(Max Delbrück Center), Ying Huang
Cited by 0
Related Papers
Antibody validation
|BioTechniques|2010|601
Linear Motif Atlas for Phosphorylation-Dependent Signaling
|Science Signaling|2008|465
Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma
|Clinical Cancer Research|2018|176
Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement
|JCI Insight|2018|162
In Situ Identification of Putative Cancer Stem Cells by Multiplexing ALDH1, CD44, and Cytokeratin Identifies Breast Cancer Patients with Poor Prognosis
|American Journal Of Pathology|2010|154